Sentinel lymph node biopsy in breast cancer Experience with the Combined Use of Dye and Radioactive Tracer at Aarhus University Hospital

One hundred and twenty-four patients with palpable tumours underwent sentinel lymph node biopsy (SLNB) and subsequent axillary lymph node dissection. Ultrasound of the axilla was used as part of the diagnostic work-up on all patients and those with lymph node metastasis verified by fine-needle aspiration biopsy (FNAB) were not included. For identifying the SLNs, a combination of Tc-99m-labelled human albumin (Solco-ALBU-RES) and blue dye (Patent Blue V) was used. No lymphoscintigraphy was performed. The SLN was successfully identified in 122 out of 124 (98%) patients and 66 (54%) patients were found to have metastatic involvement of the axillary lymph nodes. In 52 (79%) of these patients, the SLNs were the only nodes involved, 28 (54%) had micrometastasis only. The false-negative rate was 1.5%. This method has proven valid in the staging of the axilla in patients with breast cancer. The advanced techniques of serial sectioning and immunohistochemical staining further improve the diagnostic advantage offered by the SLNB, as it increases the possibility of diagnosing micrometastatic deposits.

[1]  M. Kerin,et al.  Sentinel lymph node biopsy , 2004, BMJ : British Medical Journal.

[2]  夏越 祥次,et al.  免疫学的手法によるSentinel node conceptの検証 , 2003 .

[3]  A. Giuliano,et al.  Lymphoscintigraphy and Lymphatic Mapping for Identification of Sentinel Lymph Nodes , 2001, World Journal of Surgery.

[4]  D. Weaver,et al.  Radiolabeled Sentinel Node Biopsy: Collaborative Trial with the National Cancer Institute , 2001, World Journal of Surgery.

[5]  Stuart B. RenwickB.S..  Can Axillary Dissection in Breast Cancer Be Avoided?: Introduction , 2001, World Journal of Surgery.

[6]  R. Uren,et al.  Lymphatic Mapping of the Breast: Locating the Sentinel Lymph Nodes , 2001, World Journal of Surgery.

[7]  J. Peterse,et al.  Is Lymphatic Mapping in Breast Cancer Adequate and Safe? , 2001, World Journal of Surgery.

[8]  A. Giuliano,et al.  Pathologic Examination of Sentinel Lymph Node for Breast Carcinoma , 2001, World Journal of Surgery.

[9]  S. Renwick.  Can axillary dissection in breast cancer be avoided?--Introduction. , 2001, World journal of surgery.

[10]  E. Rutgers,et al.  Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer , 2000, The British journal of surgery.

[11]  Anders Lernevall,et al.  Imaging of Axillary Lymph Nodes , 2000, Acta oncologica.

[12]  P. Lilleng,et al.  'Missed' Micrometastases: The Extent of the Problem , 2000, Acta oncologica.

[13]  T. Yeatman,et al.  The significance of breast cancer lymph node micrometastases. , 1999, Surgical oncology clinics of North America.

[14]  D. Reintgen,et al.  Sentinel Node Biopsy and Cytokeratin Staining for the Accurate Staging of 478 Breast Cancer Patients , 1999, The American surgeon.

[15]  D. Reintgen,et al.  Lymphatic mapping in breast cancer. , 1999, Hematology/oncology clinics of North America.

[16]  D. Staples,et al.  Internal mammary lymphoscintigraphy. , 1999, Radiologic technology.

[17]  D. Krag.  Minimal access surgery for staging regional lymph nodes: the sentinel-node concept. , 1998, Current problems in surgery.

[18]  A E Giuliano,et al.  Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. , 1998, The New England journal of medicine.

[19]  E. Kalso,et al.  [Chronic pain and other symptoms following treatment of breast cancer]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[20]  R Fábregas,et al.  Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. , 1997, Radiology.

[21]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[22]  P. Lilleng,et al.  Breast cancer: two micrometastatic variants in the axilla that differ in prognosis , 1996, Histopathology.

[23]  M. Cummings,et al.  Occult axillary node metastases in breast cancer: their detection and prognostic significance. , 1996, British Journal of Cancer.

[24]  A. Neville.  Are breast cancer axillary node micrometastases worth detecting? , 1990, The Journal of pathology.

[25]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[26]  O. Kosunen,et al.  Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. , 1990, Annales chirurgiae et gynaecologiae.

[27]  D. Butler.  Adverse mechanical tension in the nervous system: a model for assessment and treatment. , 1989, The Australian journal of physiotherapy.

[28]  C. Hill,et al.  Is it useful to remove internal mammary nodes in operable breast cancer? , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  N. Cascinelli,et al.  Risk of Internal Mammary Lymph Node Metastases and Its Relevance on Prognosis of Breast Cancer Patients , 1983, Annals of surgery.

[30]  U. Veronesi,et al.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer , 1983, Cancer.

[31]  G. Ege.  Internal mammary lymphoscintigraphy in breast carcinoma: a study of 1072 patients. , 1977, International journal of radiation oncology, biology, physics.

[32]  U. Veronesi,et al.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five‐year results of an international cooperative study , 1976, Cancer.

[33]  G. Ege.  Internal mammary lymphoscintigraphy. The rationale, technique, interpretation and clinical application: a review based on 848 cases. , 1976, Radiology.